Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ZIMLAB.NSthis companyZIM Laboratories Limited	₹136.86	50.64×	1×	0.8×	15.48×	-129.3%	16.7%	1.5%	1.6%	2.0%	0.9%	-2.6%	0.43×	3.95×	0.44×	1.45×	0.0%	4	—	1	C-
BAFNAPH.NSBafna Pharmaceuticals Limited	₹472.80	23.31×	2.69×	1.72×	14.21×	-102.8%	13.4%	6.6%	7.4%	11.5%	7.2%	-5.1%	0.39×	1.71×	2.7×	1.57×	0.0%	5	—	1	C-
BRBROOKS.BOBrooks Laboratories Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
BROOKS.NSBrooks Laboratories Limited	₹65.75	4.44×	0.89×	1.27×	4.08×	-153.4%	21.0%	6.4%	28.7%	20.0%	4.1%	4.7%	0.07×	0.04×	6.55×	1.72×	0.0%	4	—	2	B-
GENNEX.BOGennex Laboratories Limited	₹8.93	9.38×	0.78×	1×	6.96×	-95.5%	19.4%	11.5%	10.7%	8.3%	5.6%	-42.1%	0.16×	-0.73×	4.71×	3.66×	0.0%	2	—	2	C+
MEMEDICO.BOMedico Remedies Limited	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	9.38×	0.89×	1.27×	6.96×	-102.8%	19.4%	6.6%	10.7%	11.5%	5.6%	-5.1%	0.16×	0.04×	4.71×	1.72×	0.0%	4	—	2	—